Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase vs Alteplase for Acute Ischemic Stroke on Mobile Stroke Units
NCT06498323Phase 4Recruiting
- Sponsor
- Mahidol University
- Start
- Aug 2022
- Primary completion
- Aug 2025
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of tenecteplase in ischemic stroke, sponsored by Mahidol University. Started Aug 2022; status: recruiting.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06498323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06498323.